Literature DB >> 33031001

Histopathologic and Ultrastructural Findings in Human Myocardium After Stereotactic Body Radiation Therapy for Recalcitrant Ventricular Tachycardia.

Soroosh Kiani1, Leila Kutob2, Frank Schneider2, Kristin A Higgins3, Michael S Lloyd1.   

Abstract

BACKGROUND: Stereotactic body radiation therapy (SBRT) is a novel treatment for refractory ventricular tachycardia (VT). While outcomes have been described in small studies, histological findings after SBRT for VT are unknown.
METHODS: We identified 4 explanted hearts in the context of transplant that received prior SBRT as part of an 11-patient compassionate use series at our institution. Clinical VTs and computed tomography-defined target volume areas of SBRT were correlated to the anatomic specimens. Gross pathological, histological, and ultrastructural examination of tissue in the target area of SBRT was performed.
RESULTS: All 4 patients had nonischemic cardiomyopathy, and 3 had left ventricular assist devices. In all cases, patients had recurrent sustained VT and had failed multiple antiarrhythmics and radiofrequency ablations. Four patients underwent 5 total SBRT therapy sessions with 25-Gy single-fraction dose delivered to the area of culprit scar. The time from SBRT to explant ranged from 12 to 250 days. Histopathologic features following radiation were comparable in all patients and were characterized by areas of subendocardial necrosis surrounded by a rim of fibrosis. In 1 patient, the surrounding myocardium showed cytoplasmic vacuolization in myocytes and in another patchy interstitial fibrosis. Vascular changes consisted of myointimal thickening with prominence of endothelial cells. Electron microscopy of myocardium showed irregular, convoluted intercalated disc regions, loss of contractile elements with disrupted and haphazardly arranged myofibrils, and edematous mitochondria with loss of cisternae.
CONCLUSIONS: Here, we report the first series of findings in human tissue in 4 patients after SBRT. Histopathologic features were consistent across all 4 patients and were indicative of cell injury, death, and to a lesser extent, fibrosis. Electron microscopy demonstrated features consistent with acute injury. These specimens provide radiobiological mechanisms of acute cellular injury during SBRT for VT, which may have an antiarrhythmic effect before the onset of fibrosis.

Entities:  

Keywords:  death; myocardium; radiation; radiotherapy; tachycardia, ventricular

Mesh:

Year:  2020        PMID: 33031001     DOI: 10.1161/CIRCEP.120.008753

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  9 in total

1.  Cardiac stereotactic ablative radiotherapy for control of refractory ventricular tachycardia: initial UK multicentre experience.

Authors:  Justin Lee; Matthew Bates; Ewen Shepherd; Stephen Riley; Michael Henshaw; Peter Metherall; Jim Daniel; Alison Blower; David Scoones; Michele Wilkinson; Neil Richmond; Clifford Robinson; Phillip Cuculich; Geoffrey Hugo; Neil Seller; Ruth McStay; Nicholas Child; Andrew Thornley; Nicholas Kelland; Philip Atherton; Clive Peedell; Matthew Hatton
Journal:  Open Heart       Date:  2021-11

2.  Non-invasive Stereotactic Body Radiation Therapy for Refractory Ventricular Arrhythmias: Venturing into the Unknown.

Authors:  Justin Hayase; Robert Chin; Minsong Cao; Peng Hu; Kalyanam Shivkumar; Jason S Bradfield
Journal:  J Innov Card Rhythm Manag       Date:  2022-02-15

3.  Surgical ablation after stereotactic body radiation therapy for ventricular arrhythmias.

Authors:  Justin Hayase; Robert Chin; Murray Kwon; Minsong Cao; Peng Hu; Olujimi Ajijola; Noel Boyle; Kalyanam Shivkumar; Jason S Bradfield
Journal:  HeartRhythm Case Rep       Date:  2021-11-03

4.  Successful ventricular tachycardia radioablation in a patient with previous chemical pleurodesis: A case report.

Authors:  Chiara Pavone; Roberto Scacciavillani; Maria Lucia Narducci; Francesco Cellini; Gemma Pelargonio; Gianluigi Bencardino; Francesco Perna; Francesco Spera; Gaetano Pinnacchio; Tommaso Sanna; Vincenzo Valentini; Filippo Crea
Journal:  Front Cardiovasc Med       Date:  2022-07-18

Review 5.  Stereotactic Radiotherapy: An Alternative Option for Refractory Ventricular Tachycardia to Drug and Ablation Therapy.

Authors:  Wenfeng Shangguan; Gang Xu; Xin Wang; Nan Zhang; Xingpeng Liu; Guangping Li; Gary Tse; Tong Liu
Journal:  J Clin Med       Date:  2022-06-20       Impact factor: 4.964

6.  One-Week Dynamic Changes in Cardiac Proteomes After Cardiac Radioablation in Experimental Rat Model.

Authors:  Byoung Hyuck Kim; Jin Woo Jung; Dohyun Han; Myung-Jin Cha; Ji Hyun Chang
Journal:  Front Cardiovasc Med       Date:  2022-06-28

7.  Histopathological Examination of an Explanted Heart in a Long-Term Responder to Cardiac Stereotactic Body Radiotherapy (STereotactic Arrhythmia Radioablation).

Authors:  Marcin Miszczyk; Mateusz Sajdok; Jerzy Nożyński; Magdalena Cybulska; Jacek Bednarek; Tomasz Jadczyk; Tomasz Latusek; Radoslaw Kurzelowski; Łukasz Dolla; Wojciech Wojakowski; Agnieszka Dyla; Michał Zembala; Anna Drzewiecka; Konrad Kaminiów; Anna Kozub; Ewa Chmielik; Aleksandra Grza Dziel; Adam Bekman; Krzysztof Stanisław Gołba; Sławomir Blamek
Journal:  Front Cardiovasc Med       Date:  2022-07-07

8.  Stereotactic body radioablation therapy as an immediate and early term antiarrhythmic palliative therapeutic choice in patients with refractory ventricular tachycardia.

Authors:  Dursun Aras; Elif Hande Özcan Çetin; Huseyin Furkan Ozturk; Elif Ozdemir; Meryem Kara; Firdevs Aysenur Ekizler; Ozcan Ozeke; Firat Ozcan; Ahmet Korkmaz; Umit Kervan; Nesrin Turhan; Nazim Coskun; Yilmaz Tezcan; Henry Huang; Tolga Aksu; Serkan Topaloglu
Journal:  J Interv Card Electrophysiol       Date:  2022-08-30       Impact factor: 1.759

Review 9.  The effect of ionizing radiation through cardiac stereotactic body radiation therapy on myocardial tissue for refractory ventricular arrhythmias: A review.

Authors:  John Whitaker; Paul C Zei; Shahreen Ahmad; Steven Niederer; Mark O'Neill; Christopher A Rinaldi
Journal:  Front Cardiovasc Med       Date:  2022-09-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.